![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 31, 28230-28240, August 5, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Glutamylcysteine Synthetase Heavy Subunit mRNA Stability by Oxidative Stress Involving p38 Mitogen-activated Protein Kinase Signaling*


From the Department of Molecular Pathology, the University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Expression of the
-glutamylcysteine synthetase heavy subunit (
-GCSh), which encodes the rate-limiting enzymes for glutathione biosynthesis, is regulated by many cytotoxic agents. Moreover,
-GCSh mRNA expression is elevated in colorectal cancer, but how
-GCSh expression is regulated is not completely understood. By using actinomycin D, which inhibits new RNA synthesis, we showed that treatment of human colorectal cancer cells with the prooxidant sulindac increased the half-life of
-GCSh mRNA. By using a tetracycline-regulated
-GCSh mRNA assay system, we systematically dissected the cis-acting sequence and trans-acting factors that regulate the stability of
-GCSh by cytotoxic prooxidants. We demonstrated that a HuR recognition sequence, AUUUA, in the 3'-untranslated region is responsible for the decay of
-GCSh mRNA. Oxidative stress enhanced cytoplasmic content of HuR. Overexpression of HuR by transfection stabilized
-GCSh mRNA, whereas overexpression of a dominant-negative HuR mutant suppressed the induced stability. Furthermore, prooxidant-induced
-GCSh mRNA stabilization and HuR binding were blocked by p38 mitogen-activated protein kinase inhibitors. We provide the first evidence that reduction-oxidation regulation of
-GCSh expression, itself a reduction-oxidation sensor and regulator, is mediated at least in part by the p38 mitogen-activated protein kinase signaling through the HuR RNA-binding protein.
Received for publication, November 19, 2004 , and in revised form, May 27, 2005.
* This work was supported in part by NCI, National Institutes of Health Grants CA79085, CA72404 (to M. T. K.), and CA16672 (Cancer Center Core) from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported in part by the post-doctoral fellowship program of the Korean Science and Engineering Foundation.
To whom correspondence should be addressed: Dept. of Molecular Pathology, Unit 89, the University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Tel.: 713-792-3214; Fax: 713-792-8424; E-mail: tkuo{at}mdanderson.org.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. H. W. Chen, I.-S. Song, A. Hossain, M.-K. Choi, Y. Yamane, Z. D. Liang, J. Lu, L. Y.-H. Wu, Z. H. Siddik, L. W. J. Klomp, et al. Elevated Glutathione Levels Confer Cellular Sensitization to Cisplatin Toxicity by Up-Regulation of Copper Transporter hCtr1 Mol. Pharmacol., September 1, 2008; 74(3): 697 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Quann, F. Khwaja, and D. Djakiew The p38 MAPK Pathway Mediates Aryl Propionic Acid Induced Messenger RNA Stability of p75NTR in Prostate Cancer Cells Cancer Res., December 1, 2007; 67(23): 11402 - 11410. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |